We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XPHYF market cap is 30.45M. The company's latest EPS is CAD -0.0719 and P/E is -3.62.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 208k | 345k | 286k | 297k | 372k |
| Operating Income | -5.54M | -11.13M | -14.37M | -9.2M | -2.59M |
| Net Income | -7.67M | -16.89M | -20.64M | -12.38M | -7.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 8.66M | 8.28M | 9.73M | 1.61M | 1.27M |
| Total Liabilities | 2.33M | 4.28M | 8.06M | 5.74M | 6.55M |
| Total Equity | 6.32M | 4.01M | 1.67M | -4.13M | -5.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.69M | -10.2M | -12.16M | -6.23M | -5.17M |
| Investing | -462k | -156k | -5.31M | -4k | 101k |
| Financing | 2.08M | 12.65M | 16.23M | 5.02M | 5.29M |
| Market Cap | 30.45M |
| Price to Earnings Ratio | -3.62 |
| Price to Sales Ratio | 74.29 |
| Price to Cash Ratio | 76.47 |
| Price to Book Ratio | -5.28 |
| Dividend Yield | - |
| Shares Outstanding | 107.35M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.34 (57.26%) |
| Company Name | BioNxt Solutions Inc (QB) |
| Address |
1500 – 1055 west georgia street vancouver, british columbia V6E 4N7 |
| Website | https://www.bionxt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
